How Does Imaging Support the Development of New Therapeutics

Antibody-drug conjugates (ADCs) and radioisotope therapies (RITs) offer targeted therapies that effectively attack tumor cells while minimizing harm to surrounding healthy tissue. However, the right design of ADC and RIT trials is critical. This resource explores the pivotal role advanced medical imaging plays in improving clinical trial design and patient access to cutting-edge treatment options.